Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TE
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
YUMA
3226
DELISTED
Yuma Energy Inc
YUMA
| $66K | ﹤0.01% |
883
-1
| -0.1% | -$74 |
2014 Q3
8 quarters
|
|
3227
Marathon Digital Holdings
MARA
$3.74B
| $65K | ﹤0.01% |
1,444
+738
| +105% | +$34.2K |
2016 Q2
1 quarter
|
|
|
IKGH
3228
DELISTED
Iao Kun Group Holding Company Limited
IKGH
| $64K | ﹤0.01% |
+190,376
| New | +$135K |
2016 Q3
0 quarters
|
|
|
AIXG
3229
DELISTED
Aixtron SE
AIXG
| $64K | ﹤0.01% |
+10,525
| New | +$64.1K |
2016 Q3
0 quarters
|
|
|
GRCE
3230
Grace Therapeutics
GRCE
$42.9M
| $63K | ﹤0.01% |
738
+94
| +15% | +$6.96K |
2015 Q2
5 quarters
|
|
|
AHPI
3231
DELISTED
Allied Healthcare Products
AHPI
| $63K | ﹤0.01% |
38,400
+13,650
| +55% | +$16.6K |
2014 Q4
7 quarters
|
|
|
CETV
3232
DELISTED
Central European Media Enterprises Ltd
CETV
| $63K | ﹤0.01% |
+27,179
| New | +$62.3K |
2016 Q3
0 quarters
|
|
3233
Koss Corp
KOSS
$34.9M
| $62K | ﹤0.01% |
28,600
+900
| +3% | +$1.87K |
2014 Q2
9 quarters
|
|
3234
Precipio
PRPO
$41.6M
| $62K | ﹤0.01% |
24
+12
| +100% | +$41.1K |
2015 Q4
3 quarters
|
|
|
BIOL
3235
DELISTED
Biolase, Inc.
BIOL
| $62K | ﹤0.01% |
+3
| New | +$53.4K |
2016 Q3
0 quarters
|
|
|
CDTI
3236
DELISTED
CDTI Advanced Materials, Inc. Common Stock
CDTI
| $62K | ﹤0.01% |
3,435
+2,568
| +296% | +$43.9K |
2016 Q2
1 quarter
|
|
|
KGJI
3237
DELISTED
Kingold Jewelry Inc.
KGJI
| $61K | ﹤0.01% |
4,506
-1,311
| -23% | -$16.5K |
2014 Q1
10 quarters
|
|
3238
Riot Platforms
RIOT
$6.28B
| $60K | ﹤0.01% |
19,686
+7,953
| +68% | +$27.8K |
2016 Q2
1 quarter
|
|
3239
WidePoint Corp
WYY
$72.2M
| $60K | ﹤0.01% |
+14,160
| New | +$74.2K |
2016 Q3
0 quarters
|
|
|
BDR
3240
DELISTED
Blonder Tongue Laboratories Inc
BDR
| $60K | ﹤0.01% |
98,000
+17,900
| +22% | +$10.3K |
2014 Q3
8 quarters
|
|
3241
Dare Bioscience
DARE
$15.2M
| $59K | ﹤0.01% |
472
-67
| -12% | -$15K |
2016 Q1
2 quarters
|
|
3242
RAVE Restaurant Group
RAVE
$32.7M
| $59K | ﹤0.01% |
+19,500
| New | +$74.1K |
2016 Q3
0 quarters
|
|
3243
Tenax Therapeutics
TENX
$70.4M
| $58K | ﹤0.01% |
+1
| New | +$78.9K |
2016 Q3
0 quarters
|
|
|
RESN
3244
DELISTED
Resonant Inc.
RESN
| $58K | ﹤0.01% |
+10,700
| New | +$54.8K |
2016 Q3
0 quarters
|
|
|
ONCT
3245
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $57K | ﹤0.01% |
+52
| New | +$45.4K |
2016 Q3
0 quarters
|
|
|
NAK
3246
Northern Dynasty Minerals
NAK
$646M
| $56K | ﹤0.01% |
79,208
+53,608
| +209% | +$36.3K |
2016 Q2
1 quarter
|
|
|
TMQ
3247
Trilogy Metals
TMQ
$515M
| $55K | ﹤0.01% |
100,601
+8,800
| +10% | +$5.06K |
2015 Q3
4 quarters
|
|
|
ROX
3248
DELISTED
Castle Brands, Inc.
ROX
| $52K | ﹤0.01% |
60,189
+24,289
| +68% | +$21K |
2016 Q2
1 quarter
|
|
|
ZNB
3249
Zeta Network Group
ZNB
$892K
| – | – |
0
| – | – |
2014 Q4
7 quarters
|
|
|
WINT
3250
DELISTED
Windtree Therapeutics Inc
WINT
| $51K | ﹤0.01% |
19,891
-13,100
| -40% | -$28.5K |
2015 Q4
3 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.